FX Shoulder Prospective Clinical Study
Recruiting · NCT06078865
Conditions: Osteoarthritis Shoulder, Rotator Cuff Syndrome of Shoulder and Allied Disorders, Fracture, Shoulder
At a glance
- Research payments reported, 2025
- $356,900
- U.S. investigators named
- 0
- Sites paid
- 0
- Planned or actual enrollment
- 600
About the trial
- Sponsor
- FX Shoulder Solutions
- Tested
- FX Artificial Shoulder Prosthesis (device)
- Dates
- Started 2021-03-31; completion 2031-12-30
- Results posted
- Not yet
Prospective Multi-Center Registry on study subjects with implanted devices marketed and legally commercialized in the USA by FX Shoulder Solutions.
From ClinicalTrials.gov, last updated 2026-02-09. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Fx Shoulder Solutions, Inc reported $356,900 in research payments for this study in 2025 (4 payments).
Products named: Fx V 135, Fx V 135 Stem
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
Sites paid to run it
- $356,900
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.